Navigation Links
Medical ethics experts identify, address key issues in H1N1 pandemic
Date:9/23/2009

inciples that govern an H1N1 vaccination program, it is first essential to determine the purpose of the program. Are public health officials primarily making the vaccine available to Canadians for their own protection? In this instance autonomy of decision-making and individual liberty would predominate as guiding principles. Under these circumstances there can be little justification of any coercion on the part of public health officials, in particular the use of mandatory vaccination legislation, and the government's reciprocal responsibilities to vaccine recipients are limited.

"Or is the objective of the program to reduce the population health effects of the virus? In this case principles of solidarity and the protection of the public from harm could predominate over individual liberty. Public health officials can be justified in introducing more coercive policies. However, accompanying this infringement of individual liberty is an increase in the government's reciprocal responsibilities to vaccine recipients."

Rarely, some individuals may be harmed by a mass vaccination program and "the more coercive the strategy, the greater are the reciprocal responsibilities of the state to the vaccine recipients.

"Two key elements of reciprocity would include the creation of enhanced (vaccine) safety and effectiveness post market surveillance and the introduction of a no-fault compensation program for post-vaccination adverse events."

Restrictive measures

Governments may need to limit three basic personal freedoms mobility, freedom of assembly, and privacy in order to protect the public good.

JCB authors ask readers to imagine an order by public health officials to close community centers and cancel all large public gatherings.

One family, whose two daughters were killed in a car accident, plans to hold a large memorial service with family and friends the following day with over 500 attend
'/>"/>

Contact: terrycollins@rogers.com
terrycollins@rogers.com
416-538-8712
University of Toronto Joint Center for Bioethics
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Animal studies suggest that adding flaxseed oil to... post-menopausal women and women with diabetes, ac...ational Journal of Food Safety, Nutrition and Publ...tional Research Center, in Cairo, Egypt, have stud...uated how flaxseed oil in the diet might delay the...
(Date:11/23/2009)...Since 1996, crop plants genetically modified to pr... insects, yet safe for people, have been planted o...pularity of these Bt crops, named after the bacter...lity to kill some major pests, allowing farmers to...ducing insecticide sprays. , However, since inse...
(Date:11/23/2009)...ding drug to chemo regimen may improve patient out.... 23 (HealthDay News) -- A new combination drug th...nced biliary-tract cancers, researchers say. , ...Cancer Center in Boston found that survival and tu...(Avastin), an angiogenesis inhibitor that has help...
(Date:11/23/2009)...V patients who have it take longer to get sick, st... News) -- Scientists report that a genetic variati... progression in HIV-infected patients. , In f... longer to develop AIDS and die of complications o...that vary across individuals that make a person mo...
(Date:11/23/2009)...,, ,, NASHVILLE,Tenn.,Nov.23/PRNewswire...gedcaremarketintelligence,reportsthatself-insuredm...thCareGrouphaveexperiencedanaggregatehealthcare-co...tthreeyearsofparticipationinahigh-performanceprovi... thecoalitionfoundtheseself-insuredmembercompanies...
Breaking Medicine News(10 mins):Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2
...is about the same as using drugs for treatment, st...y News) -- Giving blood transfusions to treat anem...ially lethal blood clots, say University of Roches...lyzed data on more than 70,500 cancer patients who...
...28 HMS Holdings Corp.,(Nasdaq: HMSY ) today ann...er,Jaffray Healthcare Conference, which will be he.... , Walter Hosp, CFO, will present on Tuesday, D...rity services for government healthcare programs.,...
...ght boost understanding of the disease generally, ...hDay News) -- The adult children of people with th... being sought for a new study to better understand...nset form of Alzheimer,s are needed for the six-ye...
...cals make some playthings unfit for kids, report c... -- Plastic fish squirt guns and plastic ponies co...ates. , Toy cars and toy earrings laced with lead....day season, but that they shouldn,t find their way...
..., Nov. 28 VIDA Diagnostics Inc. announced,today t... (PW2) has obtained,FDA 510(k) clearance for sale....ng image analysis software from,VIDA and comprises...ystem measurement functions. , "We are privi...
... Serving as a model for public health a...organization has launched the D*action Community P...nd individuals committed to solving the worldwide ... p.m. , San Diego, CA (PR...
Other Medicine News:Health News:Transfusing Anemic Cancer Patients Boosts Clot Risk 2Health News:Study Recruiting From Alzheimer's-Prone Families 2Health News:Beware of Toxic Toys This Holiday Season 2Health News:Beware of Toxic Toys This Holiday Season 3Health News:VIDA Diagnostics Gains FDA Approval for Comprehensive Lung Analysis Software 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3
(Date:11/23/2009)...BridgePointMedicalannouncedtodaythatitreceivedEuro...ripheralChronicTotalOcclusion(CTO)CrossingSystemco...Stingray®CTORe-EntrySystem.TheBridgePointSyst...dtonavigatehighlydiseasedarteriesinpreparationforb..., TheNationalHeart,LungandBloodInstitute(NHLBI)est...
(Date:11/23/2009)...wire-FirstCall/-- LexiconPharmaceuticals,Inc. (Nas...hase2clinicalstudywith LX1031 inpatientswithnon-co...edatGASTRO2009inLondonthisweek.Resultsfromthestudy...illbepresentedbyDr. PhilipM.Brown ,Lexicon,ssenior...09at2:30pmlocaltimeatthesessionentitled,"Therapeut...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Obama Signs Tough New Anti Smoking Law 49671 1Obama Signs Tough New Anti Smoking Law 49671 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 1Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 3Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 4Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 5Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 6Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 7Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
... Va., Jan. 4 Innocoll, Inc., a privately-held,spe...first of a series of,planned phase 2 clinical tria...ll Technologies Ltd, to investigate CollaRx(R) BUP...st-operative pain, has commenced dosing., Innocol...e and fully,bioresorbable matrix of purified fibri...
...Calif., Jan. 3 Watson,Pharmaceuticals, Inc. (NYSE...ny, announced today it has launched Clarithromycin...gth. Watson,s Clarithromycin,Extended-Release prod...),XL, which is indicated to treat or prevent infec...caused by susceptible bacteria. For the 12-months,...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4Watson Launches Generic Biaxin(R) XL 2
8-multi channel rack
...c PTFE membranes,Millex filter units with hydropho...ing filtration of gases, for venting of sterile co...c solutions. Ready-to-use sterile 25 mm Millex fil...ections; other filter units can be autoclaved prio...
...icity personal water system is an economical alter... water. In addition to the ongoing expense to purc...y applications may be at risk - as contamination c...lity to degrade over time. Simplicity ultrapure wa...
...r, , Ultrapure Water Quality On Demand, The Super-...lish" to water which has been pretreated by revers...lus systems consistently produce ultrapure water q...cations.,The Super-Q Plus water system features a ...
Medicine Products: